A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 9.92% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 3.57%. Over the past 30 days, the price of GOSS has leaped by -15.74%. And in the last five days, it has fallen by -22.32%.
Gossamer Bio Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1.55 on 02/20/25, while the lowest value for the same period was recorded at $0.50 on 06/10/24.
52-week price history of GOSS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Gossamer Bio Inc’s current trading price is -35.85% away from its 52-week high, while its distance from the 52-week low is 99.14%. The stock’s price range during this period has varied between$0.50 and $1.55. The Gossamer Bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.37 million for the day, a figure considerably higher than their average daily volume of 1.46 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Gossamer Bio Inc (GOSS) has experienced a quarterly rise of 16.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 225.92M and boasts a workforce of 145 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0127, with a change in price of +0.1080. Similarly, Gossamer Bio Inc recorded 1,535,877 in trading volume during the last 100 days, posting a change of +12.19%.
GOSS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for GOSS stands at 6.88. Similarly, the long-term debt-to-equity ratio is also 6.85.
GOSS Stock Stochastic Average
Gossamer Bio Inc’s raw stochastic average for the past 50 days is presently 18.28%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 3.72%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 10.20% and 14.78%, respectively.
